A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema

Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema Herantis Pharma Plc Company release…

Read More

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 30 May 2018 at 9:30 am Herantis Pharma Oyj - Managers'…

Read More

Herantis Pharma awarded Innovation prize of the Chemical Industry Federation of Finland

Herantis Pharma awarded Innovation prize of the Chemical Industry Federation of Finland Herantis Pharma Plc Press release 19 Apr 2018…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.